In India, the government has already issued advisories asking people to avoid travelling to countries, where Zika cases have been reported. International airports have been instructed to put up signs asking incoming passengers to report conditions like fever, body rash, joint pains and conjunctivitis - the usual symptoms of Zika infection - within two weeks of travel. Besides, the health ministry has set up a technical committee to keep close tabs on the global Zika scenario and evolve a plan of action to stem breeding of Aedes mosquitoes. The report of this panel and implementation of its recommendations must be swift. Zika is not as deadly as Ebola, but the consequences of its infection are no less disquieting, especially in the case of expectant mothers. It is linked to microcephaly - a condition in which babies are born with unusually small heads and damaged brains. Over 3,700 cases of this abnormality have already been reported from Brazil. If this virus comes to India, the count of babies with such defects would be mind-boggling.
The Zika virus is disseminated though the same species of day-biting mosquitoes - Aedes aegypti - which transmit dreaded diseases like dengue, chikungunya and Japanese encephalitis. The chances of its rapid spread in countries like India, where these maladies and their vectors already exist, are rather high. Controlling the mosquitoes is a must to prevent it. But this has been difficult in the past. Fighting Zika is tough also because those infected may not show any visible symptoms - but yet serve as potent disseminators of the virus through mosquitoes. Tracking the movement of the infection is, therefore extremely difficult. Worse still, there is no known cure or vaccine for it on the horizon.
Out-of-the-box strategies are, therefore, needed to keep this menace at bay. One possibility is to lift the ban on dichloro-diphenyl-trichloroethane or DDT, the most powerful and effective pesticide against mosquitoes. Another possibility is to use the recently evolved genetically modified mosquito that can inhibit the growth of its own species. It carries a lethal gene which causes its offspring to die before being able to bite human beings. Brazil is trying this out on a pilot basis, claiming 80 to 90 per cent success. However, there is no escape from redoubling efforts to develop drugs or vaccines to cure or prevent this infection.
You’ve reached your limit of 5 free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app